Impact of Open-Label Design on Patient-Reported Outcomes (PROs) Data in Randomized Clinical Trials of Immuno-Oncology (IO) Agents in Patients with Advanced or Metastatic Cancer: A 10-year systematic literature review (SLR)
2019 ◽
Vol 30
◽
pp. xi59-xi60
A. Anota
◽
A. Pozet
◽
C. Lefevre
◽
H. Lemasson
◽
F.-E. Cotte
◽
...
2021 ◽
Vol 19
(3.5)
◽
pp. HSR21-067
Kajal Patel
◽
Soham Shukla
◽
Jennifer Hanlon
◽
Kelly Bell
◽
Laurie Eliason
◽
...
Qiufei Ma
◽
Yingxin Xu
◽
Rajni Srivastava
◽
Namita Kaushik
◽
Mandeep Kaur
◽
...
2012 ◽
Vol 15
(4)
◽
pp. A226
B. Seal
◽
K. Puto
◽
P.D. Allen
◽
C.V. Asche
S. Rodrigues-Manica
◽
J. Leite Silva
◽
A.R. Machado
◽
C. Coelho
◽
J. Duarte
◽
...
L. Dorme
◽
M. Pe
◽
C. Coens
◽
E.M. Basch
◽
M. Calvert
◽
...
2012 ◽
Vol 22
(6)
◽
pp. 1161-1175
◽
Michael Brundage
◽
Jane Blazeby
◽
Dennis Revicki
◽
Brenda Bass
◽
Henrica de Vet
◽
...
2013 ◽
Vol 32
(2)
◽
pp. 213-223
◽
Lea Bollhalder
◽
Alena M. Pfeil
◽
Yuki Tomonaga
◽
Matthias Schwenkglenks
2019 ◽
Vol 29
(4)
◽
pp. 867-878
◽
E. Charton
◽
B. Cuer
◽
F. Cottone
◽
F. Efficace
◽
C. Touraine
◽
...
Close
Export Citation Format
Close
Share Document
Close